Domů › Kolorektální karcinom › Washington › Seattle
Klinické studie Kolorektální karcinom v Seattle, WA
34 studií pro Kolorektální karcinom hledá účastníky v lokalitách v Seattle a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Probíhá náborFáze 3
- University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 281451, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- a dalších 1
Family Communications After Genetic Testing
Probíhá náborVítáni zdraví dobrovolníci
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- a dalších 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Probíhá náborFáze 1
- Fred Hutchinson Cancer Center, Seattle
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Probíhá náborFáze 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Probíhá náborFáze 2
- Virginia Mason Medical Center, Seattle
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 2
- University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 271298, Seattle
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center, Seattle
- a dalších 1
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Probíhá náborObservační studie
- Fred Hutchinson Cancer Center, Seattle
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Probíhá náborFáze 1
- Swedish Cancer Institute, Seattle
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Probíhá náborFáze 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Probíhá náborFáze 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Probíhá náborFáze 2/3
- Local Institution - 0253, Seattle
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Probíhá náborFáze 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Probíhá náborFáze 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
Probíhá nábor
- Benaroya Research Institute at Virginia Mason, Seattle
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Probíhá náborFáze 2
- Swedish Cancer Institute, Seattle
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Probíhá náborFáze 1
- Fred Hutchinson Cancer Center, Seattle
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Probíhá náborObservační studie
- University of Washington, Seattle
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Probíhá náborFáze 1
- Fred Hutchinson Cancer Center, Seattle
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Probíhá náborFáze 1
- University Of Washington, Seattle
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Probíhá náborVítáni zdraví dobrovolníci
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Probíhá náborFáze 1/2
- Fred Hutchinson Cancer Center, Seattle
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Probíhá náborFáze 1
- Fred Hutchinson Cancer Center, Seattle
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Probíhá náborFáze 1/2
- Virginia Mason Medical Center, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Probíhá náborFáze 1/2
- Virginia Mason Medical Center, Seattle
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Probíhá náborFáze 3Vítáni zdraví dobrovolníci
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- a dalších 1
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Probíhá náborFáze 1/2
- Fred Hutchinson Cancer Center, Seattle
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Probíhá náborObservační studie
- Kaiser Permanente Washington, Seattle
- Swedish Medical Center-First Hill, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Probíhá náborFáze 1/2
- Fred Hutch Cancer Center, Seattle
ColoCare Study - Colorectal Cancer Cohort
Probíhá náborObservační studie
- FHCRC, Seattle
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Probíhá náborObservační studie
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Probíhá náborFáze 2
- Fred Hutchinson Cancer Center, Seattle
Studie Kolorektální karcinom v jiných městech
- Houston, TX102 studií
- New York City, NY77 studií
- Nashville, TN69 studií
- Boston, MA63 studií
- Los Angeles, CA59 studií
- Arlington, VA52 studií
- St. Louis, MO50 studií
- San Antonio, TX46 studií
- Philadelphia, PA44 studií
- Grand Rapids, MI40 studií
- Baldwin Park, CA38 studií
- Tampa, FL33 studií
Další studie v Seattle
- Nemalobuněčný plicní karcinom53 studií
- Rakovina (všechny typy)49 studií
- Rakovina prostaty42 studií
- Akutní myeloidní leukemie40 studií
- Rakovina prsu39 studií
- Metastatický karcinom39 studií
- Rakovina plic33 studií
- Rakovina vaječníků30 studií
- Mnohočetný myelom22 studií
- Myelodysplastické syndromy21 studií
- Akutní lymfoblastická leukemie21 studií
- Rakovina močového měchýře21 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.